Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Michael Furian (Zurich, Switzerland), Michael Furian, Mona Lichtblau, Sayaka S. Aeschbacher, Maya Bisang, Alexey Nikiforov, Tsogyal D. Latshang, Silvia Ulrich, Almaz Aldashev, Talant Sooronbaev, Konrad E. Bloch. Effect of dexamethasone on nocturnal breathing in lowlanders with COPD travelling to 3200m. Eur Respir J 2016; 48: Suppl. 60, 2392

Member's Comments

No comment yet.

Related content which might interest you: Breathing and sleep disturbances in lowlanders with COPD travelling to 2590m Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015 Cerebral oxygenation in lowlanders with COPD spending a night at 2590m Source: International Congress 2016 – Highlights in the management of COPD and beyond Year: 2016 Effect of travelling to 2590m on 6-minute walk distance, blood gases and symptoms of acute mountain sickness in COPD patients Source: International Congress 2014 – COPD: points to ponder Year: 2014 Cerebral oxygen availability limits exercise performance of lowlanders with chronic obstructive pulmonary disease (COPD) travelling to 2590m Source: International Congress 2015 – Unravelling the mechanisms of symptoms and exercise limitationas in disease Year: 2015 Effects of acetazolamide on sleep disordered breathing in patients with COPD staying at high altitude. RCT. Source: International Congress 2019 – Current perspectives in obstructive sleep apnoea therapeutic plans and their effects Year: 2019 Postural control in COPD patients travelling from 760 m to 3200 m; randomized trial evaluating effects of dexamethasone Source: International Congress 2016 – Multidimensional and multidisciplinary approaches to respiratory problems Year: 2016 Nocturnal and exercise oxygen desaturation in COPD patients with and without OSAS Source: Annual Congress 2013 –Sleep disordered breathing in special situations III Year: 2013 Altitude related adverse health effects in lowlanders with COPD travelling to 3200m Source: International Congress 2016 – Multidimensional and multidisciplinary approaches to respiratory problems Year: 2016 Effect of nocturnal oxygen therapy on daytime pulmonary hemodynamics in patients with COPD travelling to altitude. RCT. Source: Virtual Congress 2021 – Treatments for airway diseases Year: 2021 Nocturnal hypoxemia and depression among out-patients COPD subjects: A case-control study Source: International Congress 2014 – Evaluating sleep disordered breathing in children and adults Year: 2014 Effects of 1 year of treatment with nocturnal CPAP in overlap syndrome Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I Year: 2015 Does 6 minute walk test predict nocturnal oxygen desaturation in COPD patients? Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Sleep and breathing in COPD: does nocturnal O2 or NIV decrease mortality? Source: ERS Conference Year: 2015 Late Breaking Abstract - Effect of oxygen supplementation on sleep and nocturnal breathing in patients with chronic obstructive pulmonary disease travelling to high altitude: randomized trial Source: International Congress 2018 – What’s new in lung function and exercise assessment in COPD? Year: 2018 Effect of dexamethasone prophylaxis on sleep and breathing disturbances in high altitude pulmonary edema (HAPE) susceptible subjects after rapid ascent to 4559m Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control Year: 2010 Tiotropium respimat versus HandiHaler to improve sleeping oxygen saturation and sleep quality in COPD Source: International Congress 2014 – Evaluating sleep disordered breathing in children and adults Year: 2014 Retrospective analysis of oxygen therapy in persistent nocturnal hypoxia despite CPAP in obstructive sleep apnoea syndrome (OSAS) Source: International Congress 2014 – Sleep disordered breathing 2 Year: 2014 Long term use of CPAP therapy improves asthma's outcome in patients with asthma and sleep apnoea Source: International Congress 2014 – Real or not? The impact of OSA and CPAP on comorbid conditions Year: 2014 Effect of auto-CPAP therapy on parameters of rhinomanometry in patients with COPD combined with OSAHS Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Effect of cold stimulation over face on 6 minute walk distance (6MWD), oxygen saturation and dyspnea scores in patients with COPD Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014